Corticolimbic Degeneration and Treatment of Dementia
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The overall purpose of this research is to determine if there is a relationship between your
symptoms of Dementia of the Alzheimers type and changes in the size and shape of certain
brain structures during combined Donepezil (Aricept®) and Memantine (Namenda®) treatment.